Viewing Study NCT02263105


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-05-29 @ 2:27 AM
Study NCT ID: NCT02263105
Status: COMPLETED
Last Update Posted: 2018-07-17
First Post: 2014-09-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
Sponsor: Huashan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High-grade Gliomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent high-grade gliomas View
None cisplatin (CDDP) View
None temozolomide (TMZ) View